H2bc1 Antibody

What is H2BC1 and why is it important in epigenetic research?

H2BC1 (H2B clustered histone 1, formerly HIST1H2BA) is a histone variant with a length of 127 amino acid residues and a molecular weight of approximately 14.2 kDa . It belongs to the Histone H2B protein family and is primarily localized in the nucleus .

Recent research has revealed that H2BC1 plays a critical role in the formation of H2AK119ub nucleosomes, which are essential for Polycomb gene silencing . This modification is involved in multiple physiological processes including gene silencing, replication, DNA damage repair, X chromosome inactivation, and heterochromatin organization . The discovery that H2BC1 is a component of H2AK119ub nucleosomes has significantly advanced our understanding of epigenetic regulation mechanisms.

What tissues and cell types express H2BC1?

H2BC1 is primarily expressed in testis, and the corresponding protein is also present in mature sperm . Some studies have also detected H2BC1 expression in certain fat cells . Within the context of experimental systems, H2BC1 has been studied in various cell lines including 293T cells and mouse embryonic stem cells (mESCs) .

Tissue-specific expression analysis shows that H2BC1 is highly expressed in testes and thymus, with low levels detected in liver . Interestingly, in most tissues (except ovary and testes), H2BC1 is not the predominant variant among the five H2B variants that encode proteins with identical amino acid sequences, though there is generally good concordance in tissue-specific expression patterns across these variants .

How does H2BC1 differ from canonical H2B histones?

While H2BC1 shares the core structural properties of the H2B histone family, it has unique characteristics that distinguish it from canonical H2B histones:

• Specialized nucleosome composition: H2BC1 forms part of specialized nucleosomes containing H2AK119ub modification .

• Tissue-specific expression pattern: Unlike canonical histones, H2BC1 shows a more restricted expression pattern with enrichment in testis and thymus .

• Functional specificity: H2BC1 is specifically required for H2AK119ub formation, as knockout of H2BC1 results in reduced cellular H2AK119ub levels .

• Post-translational modifications: H2BC1 undergoes various post-translational modifications including methylation, ubiquitination, acetylation, and phosphorylation, which regulate its function .

• Genomic distribution: H2BC1 has a specific genomic binding profile that significantly overlaps with H2AK119ub, particularly in gene bodies and intergenic regions .

How should I select the appropriate H2BC1 antibody for my specific research application?

Selection of the appropriate H2BC1 antibody depends on your experimental goals and techniques:

For Western Blotting and ELISA:

• Several validated antibodies have been confirmed for these applications, including polyclonal antibodies like LS-C831240 (LSBio) and monoclonal antibodies like ABIN4317537 (antibodies-online) .

• For post-translational modification studies, use specific antibodies targeting modified residues, such as anti-Acetyl-H2BC1-Lys121 antibody .

For Immunohistochemistry (IHC):

• Multiple validated antibodies are available, including NBP2-45974 (Novus Biologicals) and TA808271 (OriGene) .

• For testis-specific studies, higher dilutions (1:35) have been reported effective .

For Immunofluorescence (IF):

• Anti-H2BC1 antibodies at 1:35 dilution have been successful for IF applications in testicular tissue .

• Consider co-staining with other markers (e.g., γ-H2A.X) for contextual analysis.

For Chromatin Immunoprecipitation (ChIP):

• For genomic binding studies, antibodies used in CUT&TAG technologies with HA-Flag-H2BC1 and Flag-H2AZ.2 KI mouse ESC lines have proven effective .

Validation table for common H2BC1 antibodies:

What controls should I include when using H2BC1 antibodies in my experiments?

Proper controls are essential for reliable interpretation of H2BC1 antibody experiments:

Positive Controls:

• Include testis tissue extracts where H2BC1 is highly expressed .

• Use anti-H4 antibody (e.g., Invitrogen 3HH4–4G8, Abcam ab7311) as a general histone positive control .

• For cell line work, include wild-type cell extracts before examining knockout/knockdown samples.

Negative Controls:

• H2BC1 knockout cell lines generated using CRISPR-Cas9 technology serve as excellent negative controls .

• Primary antibody omission controls should be included in immunostaining experiments.

• For tissue specificity, include samples from tissues with low H2BC1 expression (e.g., liver) .

Loading Controls:

• For western blotting, include antibodies against canonical histones (H3 or H4) to normalize loading .

• β-actin can serve as a general loading control for whole cell extracts .

Specificity Controls:

• Perform peptide competition assays to confirm antibody specificity.

• Use multiple antibodies targeting different epitopes of H2BC1 when possible.

• Include purified recombinant H2BC1 protein as a reference standard.

How can I design experiments to investigate the relationship between H2BC1 and H2AK119ub?

Based on recent findings about the critical role of H2BC1 in H2AK119ub formation, consider these experimental approaches:

1. Genetic Manipulation Approaches:

• Generate H2BC1 knockout or knockdown cell lines using CRISPR-Cas9 technology or RNAi approaches .

• Create rescue experiments by re-expressing wild-type or mutant forms of H2BC1 in knockout cells.

• Develop inducible expression systems to study temporal dynamics of H2BC1-H2AK119ub relationships.

2. Protein-Protein Interaction Studies:

• Perform co-immunoprecipitation experiments with H2BC1 antibodies to identify interacting partners.

• Use proximity ligation assays to study interactions between H2BC1 and RING1A (PRC1 component) .

• Apply tandem affinity purification approaches using tags like GST-UAB, Flag-H2AZ.2, and HA-H2BC1 for nucleosome composition studies .

3. Genomic Studies:

• Implement CUT&TAG technologies to map genome-wide distribution of H2BC1 and H2AK119ub .

• Compare binding profiles across different genomic regions (promoters, gene bodies, intergenic regions).

• Perform differential gene expression analysis following H2BC1 manipulation.

4. Structural Studies:

• Use cryo-EM approaches to study native H2AK119ub nucleosomes containing H2BC1 .

• Conduct mass spectrometry analysis of purified H2AK119ub nucleosomes to verify composition.

Example Experimental Workflow:

• Generate H2BC1 knockouts in relevant cell lines (293T cells, mESCs)

• Verify knockout by sequencing and Western blot

• Assess H2AK119ub levels by Western blot

• Perform genome-wide binding studies using CUT&TAG

• Analyze gene expression changes via RNA-seq

• Conduct rescue experiments with wild-type H2BC1

What are the optimal conditions for using H2BC1 antibodies in Western blotting?

For optimal Western blot results with H2BC1 antibodies, follow these methodological guidelines:

Sample Preparation:

• Extract histones using acid extraction methods (e.g., 0.2N HCl) to enrich for histone proteins.

• For whole cell lysates, use RIPA buffer supplemented with protease inhibitors and deubiquitinase inhibitors (to preserve ubiquitination states).

• Include 5-10 μg of purified histones or 20-30 μg of whole cell lysate per lane.

Gel Electrophoresis:

• Use 15-18% SDS-PAGE gels for optimal separation of low molecular weight histones.

• Include ladder markers that cover the 10-20 kDa range for accurate size determination.

Transfer Conditions:

• Transfer to PVDF membranes (preferred over nitrocellulose for small proteins).

• Use wet transfer at low voltage (30V) overnight at 4°C for efficient transfer of histones.

Antibody Incubation:

• Block membranes in 5% non-fat dry milk or 3-5% BSA in TBST.

• Dilute primary H2BC1 antibodies appropriately (typically 1:1000-2000 for Western blot) .

• Incubate with primary antibody overnight at 4°C with gentle agitation.

• Use appropriate secondary antibodies (e.g., Peroxidase AffiniPure Goat Anti-Rabbit IgG for rabbit primaries) .

Detection:

• Use enhanced chemiluminescence (ECL) detection systems.

• For quantitative analysis, consider Odyssey infrared imaging systems.

• Expected band size for H2BC1 is approximately 14.2 kDa .

Controls to Include:

• Run wild-type and H2BC1 knockout samples side by side.

• Include antibodies against canonical histones (H3 or H4) as loading controls.

How can I optimize immunofluorescence protocols for H2BC1 detection in tissue sections?

For effective immunofluorescence detection of H2BC1 in tissue sections:

Tissue Preparation:

• Fix tissues in 4% paraformaldehyde for 24 hours.

• Embed in paraffin and section at 5-7 μm thickness.

• Perform antigen retrieval using citrate buffer (pH 6.0) by heating at 95°C for 20 minutes.

Antibody Selection and Dilution:

• Use validated antibodies for IF applications (e.g., Abcam ab185682 at 1:35 dilution) .

• For co-staining applications, combine anti-H2BC1 with markers like anti-phospho-histone H2A.X (Ser139) .

Staining Protocol:

• Deparaffinize and rehydrate sections

• Perform antigen retrieval

• Block in PBS containing 10% FCS for 1-2 hours at room temperature

• Incubate with primary antibodies overnight at 4°C

• Wash 3 times with PBS

• Incubate with fluorochrome-conjugated secondary antibodies (e.g., Alexa Fluor 488 goat anti-rabbit) at 1:2000 dilution for 1 hour at room temperature

• Counterstain nuclei with Hoechst 33342 (20 mM) for 10 minutes

• Mount with ProLong Gold or similar mounting medium

Visualization:

• Use confocal microscopy for high-resolution imaging of nuclear localization patterns.

• For co-localization studies, use appropriate filter sets to visualize multiple fluorochromes.

• Quantify staining intensity using software like ImageJ.

Controls and Validation:

• Include sections from testis as positive controls .

• Use tissue from H2BC1 knockout animals as negative controls when available.

• Include secondary-only controls to assess non-specific binding.

What are the best approaches for generating H2BC1 knockout models using CRISPR-Cas9?

Several studies have successfully generated H2BC1 knockout models using CRISPR-Cas9 technology . Here's a methodological approach based on their protocols:

sgRNA Design:

• Design sgRNAs targeting exonic regions of H2BC1 to ensure functional disruption.

• Use multiple sgRNAs to increase knockout efficiency.

• Validate sgRNA specificity using online tools to minimize off-target effects.

Cell Line Selection:

• 293T cells and mouse embryonic stem cells (mESCs) have been successfully used for H2BC1 knockout .

• Choose cell lines that express detectable levels of H2BC1 protein.

Transfection Protocol:

• Co-transfect Cas9 expression vector and sgRNA expressing vectors.

• Use appropriate transfection reagents for your cell type (e.g., Lipofectamine 3000 for 293T cells).

• Include selection marker (e.g., puromycin resistance) for enrichment of transfected cells.

Knockout Verification:

• Isolate single cell clones by limiting dilution or FACS sorting.

• Perform genomic PCR and sequencing of the targeted region to confirm mutations .

• Verify protein depletion by Western blot using validated H2BC1 antibodies.

• Check for H2AK119ub levels, which should be reduced in H2BC1 knockout cells .

Functional Validation:

• Assess effects on H2AK119ub levels by Western blotting with anti-H2Aub1 antibody (Cell Signaling Technology, #5546) .

• Perform CUT&TAG or ChIP-seq to analyze genome-wide binding profiles of H2AK119ub before and after knockout .

• Examine effects on Polycomb target gene expression by RT-qPCR or RNA-seq.

How should I interpret genomic distribution data for H2BC1 binding?

Recent studies using CUT&TAG technologies have provided detailed information about the genomic distribution of H2BC1 . Here's how to interpret this data:

Distribution Across Genomic Features:

• H2BC1 is widely distributed throughout the genome, with approximately 58% located in gene or gene regulatory regions (promoters, 5' UTR, exons, introns, 3' UTR, TSS) and 42% in intergenic and non-coding regions .

• Within gene-associated regions, H2BC1 is predominantly found in introns and exons (47% of total binding) rather than promoters and 5'UTRs (9% of total binding) .

• This distribution suggests that H2BC1 likely plays important roles beyond promoter-based gene regulation, particularly in gene body functions.

Correlation with H2AK119ub:

• Approximately 61.04% of H2BC1 binding sites overlap with H2AK119ub, indicating a significant but not complete association .

• The overlap varies by genomic context, with higher overlap ratios observed in gene bodies and intergenic regions compared to promoter regions .

• The incomplete overlap suggests that H2BC1 may have additional functions independent of H2AK119ub formation.

Co-occurrence with H2AZ.2:

• About 61.21% of H2BC1 binding sites overlap with H2AZ.2 .

• Approximately 45.99% of H2BC1 sites overlap with both H2AK119ub and H2AZ.2, suggesting a functional unit formed by these three components .

Functional Interpretation:

• The enrichment of H2BC1 in gene bodies suggests potential roles in transcriptional elongation, RNA processing, or other gene body-associated functions.

• The significant but incomplete overlap with H2AK119ub indicates that not all H2BC1-containing nucleosomes are ubiquitinated.

• The distribution pattern suggests that H2BC1 may have context-dependent functions across different genomic regions.

Visualization Approaches:

• Use genome browsers to visualize the distribution at specific loci of interest.

• Generate heatmaps centered on transcription start sites, gene bodies, or enhancers to assess patterns of enrichment.

• Create Venn diagrams to illustrate the overlap between H2BC1, H2AZ.2, and H2AK119ub binding sites.

What explains the relationship between H2BC1, H2AZ.2, and H2AK119ub in nucleosome composition?

The complex relationship between H2BC1, H2AZ.2, and H2AK119ub has been elucidated through biochemical and structural studies :

Nucleosome Composition Model:

• H2AK119ub nucleosomes contain the histone variants H2BC1 and H2AZ.2, forming a specialized nucleosome with unique properties .

• This composition is critical for H2AK119ub formation, as knockout of either H2BC1 or H2AZ.2 reduces cellular H2AK119ub levels .

Structural Insights:

• Cryo-EM studies have resolved the structure of native H2AK119ub nucleosomes to 2.6Å resolution, confirming the presence of H2BC1 in at least one subgroup of H2AK119ub nucleosomes .

• The specific structural features of H2BC1-containing nucleosomes may facilitate ubiquitination by PRC1 components.

Functional Heterogeneity:

• Tandem pulldown experiments indicate that H2AK119ub nucleosomes can be separated into distinct subgroups, suggesting compositional heterogeneity .

• Not all H2BC1 or H2AZ.2 is associated with H2AK119ub, indicating they likely have additional functions beyond H2AK119ub formation .

Interpretation Framework:

• H2BC1 and H2AZ.2 create a specialized nucleosome environment that facilitates H2A ubiquitination by PRC1.

• The specific amino acid differences in these histone variants likely create structural features that promote the recruitment or activity of ubiquitination machinery.

• The heterogeneity of H2AK119ub nucleosomes suggests that different subpopulations may serve distinct functional roles.

Research Implications:

• Studies of H2AK119ub function should consider the contribution of these histone variants.

• Targeting H2BC1 or H2AZ.2 may provide alternative approaches to modulate Polycomb-mediated gene silencing.

• The specialized composition of H2AK119ub nucleosomes may explain previous conflicting results regarding the role of H2AK119ub in gene regulation.

How can I resolve contradictory findings when studying H2BC1 function in different cell types?

When confronted with contradictory findings regarding H2BC1 function across different cell types or experimental systems, consider these analytical approaches:

Assess Tissue-Specific Expression Patterns:

• H2BC1 expression varies significantly across tissues, with highest expression in testis and thymus .

• Determine whether expression level differences might explain functional discrepancies between cell types.

• Consider the relative abundance of H2BC1 compared to other H2B variants in your specific cell type .

Evaluate Nucleosome Composition Differences:

• The functional impact of H2BC1 depends on nucleosome composition, particularly the presence of H2AZ.2 .

• Assess whether differences in H2AZ.2 or other histone variant expression might explain cell type-specific effects.

Consider Post-Translational Modification States:

• H2BC1 undergoes various modifications including methylation, ubiquitination, acetylation, and phosphorylation .

• Cell type-specific modification patterns might alter H2BC1 function.

• Use modification-specific antibodies (e.g., anti-Acetyl-H2BC1-Lys121) to assess modification states .

Analyze Genomic Distribution Patterns:

• Compare H2BC1 genomic binding profiles between cell types using CUT&TAG or ChIP-seq approaches.

• Differences in distribution may explain cell type-specific functions.

• Pay particular attention to cell type-specific genes and regulatory elements.

Examine Interaction Partners:

• H2BC1 function likely depends on its protein interaction network.

• Cell type-specific interaction partners might modify H2BC1 function.

• Use techniques like BioID or proximity ligation assays to identify cell type-specific interactors.

Methodological Considerations:

• Ensure that antibodies used across different studies have comparable specificities and epitopes.

• Account for differences in knockout efficiency or experimental approaches.

• Consider the timing of analyses, as H2BC1 function might change during cell differentiation or cell cycle progression.

Resolution Framework:

• Directly compare H2BC1 function in multiple cell types using identical experimental approaches.

• Perform rescue experiments to determine if cell type-specific factors mediate functional differences.

• Use domain swapping or mutagenesis to identify regions of H2BC1 responsible for cell type-specific functions.

• Develop computational models that incorporate cell type-specific factors to predict H2BC1 function.

How can H2BC1 antibodies be used to study the mechanism of Polycomb gene silencing?

H2BC1 antibodies provide powerful tools for investigating Polycomb gene silencing mechanisms, given the critical role of H2BC1 in H2AK119ub formation:

Chromatin State Analysis:

• Use H2BC1 antibodies in combination with anti-H2AK119ub antibodies to map chromatin domains associated with Polycomb repression .

• Perform sequential ChIP (ChIP-reChIP) to identify chromatin regions containing both H2BC1 and PRC1 components.

• Compare H2BC1 distribution with other Polycomb-associated histone marks (H3K27me3, H2AK119ub) to define Polycomb domain characteristics.

PRC1 Recruitment Mechanisms:

• Use H2BC1 antibodies in proximity ligation assays to detect direct interactions with PRC1 components like RING1A .

• Perform immunoprecipitation with H2BC1 antibodies followed by mass spectrometry to identify novel interactors.

• Compare wild-type and H2BC1 knockout cells to determine how H2BC1 affects PRC1 recruitment to target genes.

Dynamic Regulation Studies:

• Use H2BC1 antibodies in ChIP-seq experiments across developmental time points or differentiation stages.

• Track changes in H2BC1 occupancy during gene activation or repression events.

• Combine with nascent RNA sequencing to correlate H2BC1 binding with transcriptional activity.

Structural Studies:

• Use H2BC1 antibodies to purify native H2BC1-containing nucleosomes for structural analysis .

• Compare structures of nucleosomes with different compositions to understand how H2BC1 facilitates H2AK119ub.

Experimental Workflow Example:

• Map genome-wide distribution of H2BC1, H2AK119ub, and PRC1 components (RING1A/B) using ChIP-seq or CUT&TAG

• Identify key target genes for detailed mechanistic studies

• Use CRISPR-Cas9 to create H2BC1 mutations that disrupt specific interactions or functions

• Assess effects on H2AK119ub levels, PRC1 recruitment, and gene expression

• Perform rescue experiments with wild-type or mutant H2BC1 to determine critical functional domains

What approaches can be used to study the interplay between H2BC1 and other histone variants in disease contexts?

Investigating the interplay between H2BC1 and other histone variants in disease contexts requires integrated approaches:

Expression Analysis in Disease Models:

• Use H2BC1 antibodies for immunohistochemistry on disease tissue microarrays.

• Compare H2BC1 expression levels between normal and diseased tissues using Western blotting.

• Analyze public datasets for alterations in H2BC1 expression across different disease states, particularly in cancers where epigenetic dysregulation is common .

Cancer-Specific Applications:

• Assess H2BC1 expression in endocrine-resistant breast cancer, where histone variants have been implicated .

• Compare H2BC1 binding profiles between sensitive and resistant tumors using ChIP-seq.

• Investigate the relationship between H2BC1 and H2AK119ub in the context of cancer progression.

Functional Studies in Disease Models:

• Generate H2BC1 knockouts in disease-relevant cell lines to assess effects on disease phenotypes.

• Perform rescue experiments with wild-type or mutant H2BC1 to identify disease-relevant functions.

• Use H2BC1 antibodies to track changes in H2BC1 localization during disease progression.

Interaction with Disease-Associated Factors:

• Use H2BC1 antibodies in co-immunoprecipitation experiments to identify disease-specific interaction partners.

• Assess how disease-associated mutations in epigenetic regulators affect H2BC1 function or distribution.

• Investigate the interplay between H2BC1 and known disease drivers like BAP1, which regulates H2AK119ub levels .

Therapeutic Implications:

• Test whether targeting H2BC1 or its interactions can modulate disease phenotypes.

• Assess whether H2BC1 status can serve as a biomarker for disease progression or treatment response.

• Investigate whether compounds that modulate H2BC1 incorporation into nucleosomes have therapeutic potential.

Methodological Integration:

• Combine H2BC1 ChIP-seq with RNA-seq to correlate chromatin changes with gene expression alterations in disease.

• Use CRISPR screens to identify synthetic lethal interactions with H2BC1 in disease contexts.

• Apply single-cell approaches to understand heterogeneity in H2BC1 function within diseased tissues.